Morepen Lab Share Price Target A wide variety of pharmaceutical items are produced by Morepen Laboratories Limited in India and exported to other nations. The company has been successfully navigating its path since it was founded in 1984 with the goal of excelling in the wellness industry. The MOREPENLAB NSE stock hasn’t yet reached its full potential despite a strong run of financial outcomes over the last few years, with the exception of 2023. This article aims to investigate the elements that will affect the Morepen Lab Share Price Target 2025 and beyond. Additionally, it will analyse the impact of Morepen Lab Financial results 2023 on the stock value.
Morepen Lab Latest News
- Morepen Lab Share Price Today witnessed a steady downfall of 1.97%, against its previous close at Rs 50.85 per share on Wednesday.
Morepen Lab Share Price Target 2024, 2025, 2026 To 2030
Morepen Lab Share Price Target 2024 Rs 39.32, 2025 Rs 52.78, 2026 Rs 64.67, 2027 Rs 75.23, 2028 Rs 84.87, 2029 Rs 93.00, 2030 Rs 103.23.
Read More:
Mazagon Dock Share Price Target 2024, 2025, 2026, 2027 To 2030 Our Informations
Ultratech Share Price Target 2024, 2025, 2026 To 2030 More Informations
GVK Power Share Price
Morepen Lab Share Price Target 2024
Month (2024) | Maximum Target | MinimumTarget |
November | Rs 68.28 | Rs 37.31 |
December | Rs 68.88 | Rs 39.32 |
Category: Stock Market
Morepen Lab Share Price Target 2025
Month (2025) | Maximum Target | MinimumTarget |
January | Rs 70.13 | Rs 40.07 |
February | Rs 73.21 | Rs 42.42 |
March | Rs 75.25 | Rs 43.46 |
April | Rs 78.33 | Rs 44.44 |
May | Rs 77.35 | Rs 46.50 |
June | Rs 79.40 | Rs 46.54 |
July | Rs 80.49 | Rs 47.51 |
August | Rs 82.51 | Rs 48.68 |
September | Rs 83.57 | Rs 50.67 |
October | Rs 85.65 | Rs 51.64 |
November | Rs 88.63 | Rs 52.72 |
December | Rs 90.80 | Rs 52.78 |
Morepen Lab Share Price Target 2026 to 2030
Year | Maximum Target | Minimum Target |
|---|
2026 | Rs 115.79 | Rs 64.67 |
|---|
2027 | Rs 140.22 | Rs 75.23 |
2028 | Rs 164.09 | Rs 84.87 |
2029 | Rs 183.99 | Rs 93.00 |
2030 | Rs 205.01 | Rs 103.23 |
Morepen Lab Market Capitalisation: Rs 2,548 cr INR
Morepen Lab Reserves and Borrowings: Rs 786.80 cr INR and Rs 3.36 cr INR (March 2023) respectively.
Morepen Lab 52 Week High-Low: Rs 56.40 – Rs 25.10
Read More: Tarc Ltd Share Price Target
Morepen Lab Ltd Financials 2023
Revenue | 14.22B INR | -8.60% YOY |
Operating expense | 3.91B INR | 3.79% YOY |
Net Income | 386.75M INR | -61.96% YOY |
Net Profit Margin | 2.72 | -58.41% YOY |
Earnings Per Share | | |
EBITDA | 686.65M INR | -52.86% YOY |
Effective Tax Rate | 30.63% | |
Total Assets | 11.10B INR | 3.78% YOY |
Total Liabilities | 3.58B INR | -27.22% YOY |
Total Equity | 7.52B INR | |
Return on assets | 3.21% | |
Return on Capital | 4.71% | |
P/E Ratio | 33.10 | |
Dividend Yield | | |
Morepen Lab LTD Competitors (Market Cap: 2,548 crores INR)
- JB Chemicals & Pharmaceuticals Market Cap: 26,411.41 cr INR
- Piramal Pharma Ltd Market Cap: 19,440.72 cr INR
- Natco Pharma Market Cap: 17,983.30 cr INR
- Suven Pharmaceuticals Market Cap: 15,826.30 cr INR
Read More: Tata Communications Ltd Share Price Target
Points to consider before investing in Morepen Lab NSE Stock
- Small-cap firm Morepen Lab faces competition from firms in India’s pharmaceutical industry, including JB Chemicals & Pharmaceuticals, Piramal Pharma, Natco Pharma, and Suven Chemicals. The firms indicated above have a higher market capitalization in comparison, however there are also larger players in this industry, like Sun Pharma, Cipla, and Zydus Life. The pharmaceutical industry faces fierce competition, just like any other enterprise. Therefore,
- Morepen Laboratories Limited will need to regain its momentum on the stock market, and in order to do so, it will want to enhance its financial performance.
- The Morepen Lab’s yearly financial results haven’t been favourable for the business, which has investors on the exchange concerned. The MOREPENLAB NSE FY23 annual results show a decrease of -8.60% and -61.96%, respectively, in revenue (14.22) and net income (386.75M). This suggests that net profit has decreased significantly from Rs 1.02 billion in the prior year. The EBITDA has also been affected, declining by -52.86% YoY.
- Since Morepen Lab’s financial results may have had a negative impact on the shares, the company’s share prices have decreased during the past month.
Conclusion
The share price history of Morepen Labs shows that the stock has historically followed an inverted trend. The Morepen Lab Stock started trading on the National Stock Exchange in 2001 at Rs 94 per share. Since then, though, the NSE MOREPENLAB stock has experienced a number of losses. Morepen’s share price has dropped by 47.47% since it was listed on the NSE in 2001, and it is currently selling at about Rs 50 per share. But over the past five years, Morepen Lab’s shares have recovered, rising 146% since May 24th, 2019, when they were valued at Rs 20 per share. Investment success on the stock exchange requires a thorough examination of several risk factors, taking into account the reward factor and an individual’s.
FAQs
What is the NSE Morepen Lab Share Price Target 2024?
Morepen Lab Share Price Target 2024 is between Rs 68 and Rs 28.
What is the Morepen Lab Share Price Target 2025?
The target share price for Morepen Labs by 2025 is between Rs. 90 and Rs. 40.
What is the Morepen Lab Share Price Target 2026?
The target share price for Morepen Lab is expect to range from Rs 115 to Rs 64 in 2026.
What is the Morepen Lab Share Price Target 2027?
The target price for Morepen Lab shares in 2027 is between Rs 140 and Rs 75.
What is the Morepen Lab Share Price Target 2028?
The 2028 Morepen Lab share price target ranges from Rs 164 to Rs 84.
What is the Morepen Lab Share Price Target 2029?
The target share price for Morepen Labs in 2029 is between Rs 183 and Rs 93.
What is the NSE Morepen Lab Share Price Target 2030?
Morepen Lab Share Price Target 2030 is predict to remain between Rs 205 and Rs 103.
